20 results on '"Porretti L"'
Search Results
2. High frequency of anti-endomysial reactivity in candidates to heart transplant
3. Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: A case series
4. Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis
5. Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis
6. The intra-tumor heterogeneity of C19MC miRNA cluster expression mirrors the presence of the side population in HCC
7. Fas-Ligand involvement in end stage liver disease
8. Lysosomes involvement in chemoresistance of hepatocellular carcinoma cells
9. F-52 Cell marker identification in cancer stem cells (CSCs) of hepatocellular carcinoma (HCC)
10. T-44 HCC cell carries cytoplasmatic drug-storing vesicles as chemoresistance mechanism
11. F-14 Evidence of clonal evolution of tumor initiating cells in human hepatocellular carcinoma
12. 21 HETEROGENEITY OF STEM-LIKE CELLS IN HEPATOCELLULAR CARCINOMA
13. Hepatic stem cell characterization in tumoral and non-tumoral liver specimens from patients with hepatocellular carcinoma
14. Characterization of stem cell compartments in adult human liver
15. Antigen expression profile and differentiation potential of mesenchymal stem cells and hepatic stellate cells from adult human liver
16. Characterization of mesenchymal stem cells-like in human liver
17. Flow cytometry enumeration and characterization of stem cell lineages in the liver of patients with hepatic tumors
18. Correspondence
19. Definite risk for celiac disease in patients with end-stage heart failure
20. Platelet concentrates from buffy coats: Improved conditions for preparation and evaluation in routine clinical use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.